We are live on ! Find out more
ZSAN

Zosano Pharma Corporation
ZSAN

Delisted

ZSAN was delisted on the 10th of June, 2022.

Back to rankings

30 hedge funds and large institutions have $2.97M invested in Zosano Pharma Corporation in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

6% less funds holding

Funds holding: 32 → 30 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

47% less capital invested

Capital invested by funds: $5.61M → $2.97M (-$2.64M)

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$257K
2
Renaissance Technologies
Renaissance Technologies
New York
+$78.3K
3
Citigroup
Citigroup
New York
+$39.2K
4
UBS Group
UBS Group
Switzerland
+$21.9K
5
TI
Telemetry Investments
New York
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$47.2K
2
SG
StoneX Group
New York
-$34.4K
3
Millennium Management
Millennium Management
New York
-$34K
4
VF
Virtu Financial
New York
-$31K
5
JSMC
Jess S. Morgan & Co
California
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.16M +$257K +23,380 +19%
ACM
2
Aisling Capital Management
New York
$612K – – –
BlackRock
3
BlackRock
New York
$462K +$418 +38 +0.1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$203K – – –
State Street
5
State Street
Massachusetts
$98K +$5.48K +498 +4%
CDIA
6
Capital Directions Investment Advisors
Georgia
$79K +$55 +5 New
Renaissance Technologies
7
Renaissance Technologies
New York
$56K +$78.3K +7,115 New
TI
8
Telemetry Investments
New York
$47K +$18.2K +1,657 +38%
Northern Trust
9
Northern Trust
Illinois
$45K – – –
Barclays
10
Barclays
United Kingdom
$34K -$47.2K -4,285 -50%
UBS Group
11
UBS Group
Switzerland
$32K +$21.9K +1,993 +93%
Blackstone Inc
12
Blackstone Inc
New York
$28K – – –
Citigroup
13
Citigroup
New York
$28K +$39.2K +3,563 New
Morgan Stanley
14
Morgan Stanley
New York
$27K +$14.2K +1,289 +61%
IAA
15
Independent Advisor Alliance
North Carolina
$9K – – –
LPL Financial
16
LPL Financial
California
$7K -$13.9K -1,263 -60%
WAP
17
Wealthcare Advisory Partners
Pennsylvania
$7K – – –
NSIM
18
North Star Investment Management
Illinois
$6K – – –
PCIA
19
Prime Capital Investment Advisors
Kansas
$6K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$6K +$8.96K +814 New
GF
21
Gabelli Funds
New York
$5K – – –
HCM
22
Highlander Capital Management
New Jersey
$5K – – –
JSW
23
Journey Strategic Wealth
New Jersey
$5K +$3.14K +285 +100%
AAS
24
Avantax Advisory Services
Texas
$2K – – –
National Bank of Canada
25
National Bank of Canada
Quebec, Canada
$2K +$3.08K +280 New
1
2

ZSAN Hedge Fund Activity: Q1 2022 in Review

30 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q1 2022, worth a combined $2.97M — down 47% from $5.61M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ZSAN and 6 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $257K. The largest seller was Barclays, cutting an estimated $47.2K.

  • 30 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q1 2022, down from 32 in Q4 2021.
  • Funds reported $2.97M of Zosano Pharma Corporation stock for Q1 2022, down 47% quarter-over-quarter.
  • 6 funds opened new Zosano Pharma Corporation positions in Q1 2022 and 8 closed out, a net change of -2 holders.
  • The largest Zosano Pharma Corporation buyer in Q1 2022 was Vanguard Group, an estimated $257K added.
  • The largest Zosano Pharma Corporation seller in Q1 2022 was Barclays, an estimated $47.2K sold.

Based on aggregated 13F filings for Q1 2022.